Atticus Pharma
2 known investors
Atticus Pharma develops immunodermatology therapeutics using patented sustained-release technology for enhanced delivery to the viable epidermis. The company focuses on dermatological treatments leveraging its proprietary drug delivery platform.
Investors · 2
Competitors · 4
by search overlap奥科达6 shared keywordsA research-driven specialty pharmaceutical company that develops and commercializes innovative medicines through the 505(b)(2) regulatory pathway, focusing on central nervous system disorders, metabolic diseases, and orphan indications. The company operates in New Jersey and Shanghai, leveraging established molecules with proven safety profiles.
ANI Pharmaceuticals6 shared keywordsANI Pharmaceuticals is a generic and specialty pharmaceutical company that develops, manufactures, and distributes prescription drugs across multiple therapeutic areas including generics, rare diseases, and established branded products.
Actinium Pharmaceuticals, Inc.5 shared keywordsActinium is developing targeted radiotherapy treatments using Actinium-225 and related isotopes for oncology indications including prostate cancer, non-small cell lung cancer, breast cancer, and acute myeloid leukemia. The company's lead candidates include ATNM-400 for solid tumors and Actimab-A for blood malignancies.
AltaThera Pharmaceuticals4 shared keywordsAltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
Companies competing with Atticus Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Atticus Pharma Awarded $2 Million NIH Phase II SBIR Grant to Advance Topical ED Treatment - Connect Foundationconnect.org · Aug 2026Frequently asked questions
- What does Atticus Pharma do?
- Atticus Pharma develops immunodermatology therapeutics using patented sustained-release technology for enhanced delivery to the viable epidermis. The company focuses on dermatological treatments leveraging its proprietary drug delivery platform.
- Who are Atticus Pharma's investors?
- Atticus Pharma's investors include AEON Foundry, VentureSouth.